CALCRL, RAMP1: Calcitonin-gene-related peptide receptor, CALCRL/RAMP1
Complex in Homo sapiens that 1 drug acts on.
- Drugs that act on it: 1
- Approved: 1
- In phases 1 to 3: 0
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on CALCRL, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 1
| Drug | Furthest stage | Sponsor | Modality | Action | Open trials |
|---|---|---|---|---|---|
| Zavegepant | Approved | Pfizer | Small molecule | AntagonistCalcitonin-gene-related peptide receptor, CALCRL/RAMP1 antagonist | 5 |
| A Prospective Interventional Study of Intranasal Zavegepant for the Acute Treatment of Migraine | Zavegepant | Not applicable | Not yet recruiting | American Center for Psychiatry and Neurology | Oct 6, 2026 |
| Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache | Zavegepant | Phase 2 | Not yet recruiting | The University of Texas Health Science Center, Houston | Jul 20, 2026 |
| A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department | Zavegepant | Phase 1 | Recruiting | University of South Florida | Jun 25, 2026 |
| A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine | Zavegepant | Phase 1 | Recruiting | Pfizer | May 29, 2025 |
| Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications | Zavegepant | Phase 4 | Recruiting | Mayo Clinic | May 7, 2024 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2107838, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets